<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233790/bin/12885_2022_9776_Fig1_HTML.jpg"/> </div> <div class="text-side"> <h1>Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group.</h1> <p>a. Computed tomography (CT) of the head, routine examination after induction. Tumour at area of tent of cerebellum, 24 × 14 mm, with possible bleeding to tumour, irregular masses on both sides of tent of cerebellum and in interpedicular cistern. b. In the right frontal lobe, the focal lesion 19 × 19 mm with small calcifications. c. Magnetic resonance (MRI), metastases in both hemispheres, left frontal lobe 46 × 61 mm, left temporal lobe 36 × 27 mm, bleeding to tumour. d. At the right frontal lobe the focal lesion 38 × 35x36mm, with oedema; mass effect – shift of the middle line structures to the left e.) NBL undifferentiated subtype, removed CNS tumor. Hematoxylin–eosin staining, 45 × f. NBL undifferentiated subtype, in removed CNS tumor – on the right site.. Hematoxylin–eosin staining, 20x</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35752779/" target="_blank">35752779</a></p><p>Type: Premalignant/Malignant, Category: Neural or neuroendocrine</p>
</div> </div></div></body></html>